1992
DOI: 10.1002/bies.950140913
|View full text |Cite
|
Sign up to set email alerts
|

Challenges: Cell transplantation and gene therapy in muscular dystrophy

Abstract: Duchenne's muscular dystrophy (DMD), which affects 1/3500 live male births, involves a progressive degeneration of skeletal and cardiac muscle, leading to early death. The protein dystrophin is lacking in DMD and present, but defective, in the allelic, less severe, Becker muscular dystrophy and is also missing in the mdx mouse. Experiments on the mdx mouse have suggested two possible therapies for these myopathies. Implantation of normal muscle precursor cells (mpc) into mdx skeletal muscle leads to the conver… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

1994
1994
2004
2004

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(15 citation statements)
references
References 46 publications
0
15
0
Order By: Relevance
“…Thus, it will be useful to provide a scientific basis upon which alternative treatments could be developed. In addition, the actions of CTLs on muscle are believed to interfere with successful myoblast transfer or adenoviral gene delivery (50,51), both of which are potential therapies for muscular dystrophy. Therefore, a better understanding of the interactions of CTLs and muscle cells is fundamental for the success of gene therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it will be useful to provide a scientific basis upon which alternative treatments could be developed. In addition, the actions of CTLs on muscle are believed to interfere with successful myoblast transfer or adenoviral gene delivery (50,51), both of which are potential therapies for muscular dystrophy. Therefore, a better understanding of the interactions of CTLs and muscle cells is fundamental for the success of gene therapy.…”
Section: Discussionmentioning
confidence: 99%
“…The secretion of MMPs by skeletal myoblasts and satellite cells is clearly consistent with their observed ability to migrate through the basal lamina. The secretion of matrix-degrading metalloproteases could also be a n important factor in recent experiments in which skeletal muscle myoblasts transplanted into skeletal muscle (Hughes and Blau, 1990;Karpati et al, 1989Karpati et al, , 1993Naffakh et al, 1993;Tremblay et al, 1993;Morgan and Partridge, 1992;Partridge et al, 1989;Morgan et al, 1993) appear capable of passing through a n established basal lamina and fusing into existing myofibers. However, the present study indicates an absence of detectable stromelysin expression by satellite cells, which may limit their capacity to degrade basal lamina components, particularly those which are non-collagenous.…”
Section: Discussionmentioning
confidence: 99%
“…Primary myoblasts isolated from the muscle of neonatal mice and transplanted into mdx mice were the first successful stem cell transplants in the field. 89,90 Although these results were promising, the search for more pluripotent, ancestral progenitors led to the isolation of additional stem cell populations from distinct tissue compartments, such as bone marrow and stroma, muscle, skin, and heart. Isolated from fetal, neonatal, or adult mice and using Hoechst dye exclusion or preplating techniques, stem cells have been frequently transplanted into the mdx mouse, because the ability to restore dystrophin protein expression provides a useful marker of successful transplantation.…”
Section: Therapeutic Restoration Of Dgc: Stem Cell Transplantationmentioning
confidence: 99%